An Amsler grid, also known as an Amsler grid test, is a tool you can use at home to test your eyes for vision problems. It’s commonly used to test for signs of age-related macular degeneration (AMD).

The Amsler grid is a simple at-home exam people can use to detect or monitor age-related macular degeneration (AMD) and other eye problems. AMD is a common condition that causes vision loss in older ...

Wet age-related macular degeneration (AMD) happens when abnormal blood vessels leak fluid into the macula. It can cause wavy lines, blurriness, and dark spots, but not peripheral vision loss. The ...

Age-related macular degeneration (AMD) is one the most prevalent eye diseases. In the late stage of the disease, newly formed vessels in the retina alter its structure, which leads to blurry and ...

A recent review found that the performance of the Amsler grid test was not at a level that was recommended for detecting early or dry age-related macular degeneration (AMD). Age-related macular ...

—The findings about the diagnostic accuracy of the Amsler grid test for early detection of neovascular age-related macular degeneration suggest that the procedure will not replace regular ophthalmic ...

To clarify the screening potential of the Amsler grid and preferential hyperacuity perimetry (PHP) in detecting or ruling out wet age-related macular degeneration (AMD). Medline, Scopus and Web of ...

Please provide your email address to receive an email when new articles are posted on . A total of 106 eyes with glaucoma were included in the study. According to Su and colleagues, Amsler grid ...

Please provide your email address to receive an email when new articles are posted on . A computerized test was shown to be superior to the traditional Amsler grid in detecting age-related macular ...

Purpose Validating the current protocol of Amsler chart grid surveillance for the early detection of subretinal neovascular membrane (SRN) in age-related macular degeneration (AMD), and investigating ...

To assess the ability of patients to predict the need for retreatment with intravitreal ranibizumab in neovascular age-related macular degeneration (NVAMD) based on their perception of visual ...